Jersey hospital implements chemotherapy management system
April 4, 2016
The General Hospital in Jersey is installing a chemotherapy management system in its oncology department to improve the service provided to cancer patients.
The General Hospital is a 250-bed hospital based in St Helier and serves the whole island, with a population of 100,000. The system comes from UK-based JAC, and the hospital has been using its PSC pharmacy management system for a number of years.
The decision to implement the CMS chemotherapy management system was the next step in the hospital’s commitment to implementing an end-to-end medicines management platform.
CMS is a web-based platform for prescribing, scheduling and managing therapies for chemotherapy patients. The system's specialist functionality focuses on reducing errors, streamlining patient management and optimising efficiency.
"We look forward to working with JAC and harnessing their expertise to build a system that will benefit our patients by not only improving on the existing operational and governance arrangements that the pharmacy and oncology departments have in place, but also improving their overall experience at our hospital,” said Paul McCabe, chief pharmacist at the General Hospital.
By rolling out CMS, Health & Social Services (HSSD) in Jersey aims to demonstrate the potential for e-prescribing to improve patient care in oncology before rolling out an electronic prescribing and medicines administration system across the rest of the organisation.
"The contract with HSSD in Jersey is an important step forward for JAC as our cancer-services customer base continues to grow,” said Len Slawinski, oncology sales manager at JAC. “We have already signed contracts with a number of NHS Trusts, including: Queen Elizabeth Hospital King's Lynn NHS Foundation Trust; Heart of England NHS Foundation Trust; Princess Alexandra Hospital NHS Trust; and, very soon, Bedford Hospital NHS Trust too. The Jersey contract further demonstrates customer confidence and acceptance of our CMS product."
Head of health IT in Jersey, Jeff Tate, said the roll out of the CMS system would be up and running towards the end of 2016.
"We've worked closely with JAC for a number of years now and are looking forward to tackling this exciting new project with them,” said Tate. “Together I'm sure we can deliver a system that the hospital can be proud of and it will make a real difference to the care that we provide to our patients. This will also deliver another key component of the hospital electronic patient record."
With more than 35 years' experience within medicines management, JAC provides pharmacy stock control, e-prescribing and medicines administration as a single integrated system along with associated services and third-party interfaces. The company's products are used in more than half of all NHS trusts in England as well as sites in Jersey, Scotland, Wales, Northern Ireland, Ireland, Norway and South Africa.
In May 1996, JAC was acquired by Mediware and continues to operate as a wholly owned subsidiary.